Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA.
Bioinformatics. 2010 Nov 15;26(22):2863-6. doi: 10.1093/bioinformatics/btq544. Epub 2010 Sep 23.
A growing body of literature has demonstrated the potential for non-invasive diagnosis of a variety of human genetic diseases using cell-free DNA extracted from maternal plasma samples in early gestation. Such methods are of great significance to the obstetrics community because of their potential use as clinical standard of care. Proof of concept for such approaches has been established for aneuploidy and paternally inherited dominant traits. Although significant progress has recently been made, the non-invasive diagnosis of monogenic diseases that segregate in a recessive mendelian fashion is more problematic. Recent developments in microfluidic digital PCR and DNA sequencing have resulted in a number of recent advances in this field. These have largely, although not exclusively, been used for the development of diagnostic methods for aneuploidy. However, given their prevalence, it is likely that such methods will be utilized towards the development of non-invasive methods for diagnosing monogenetic disorders.
With this in mind, we have undertaken a statistical modeling of three contemporary (digital) analytical methods in the context of prenatal diagnosis using cell free DNA for monogenic diseases that segregate in a recessive mendelian fashion. We provide an experimental framework for the future development of diagnostic methods in this context that should be considered when designing molecular assays that seek to establish proof of concept in this field.
越来越多的文献表明,使用从妊娠早期母体血浆样本中提取的无细胞 DNA ,有可能对多种人类遗传疾病进行非侵入性诊断。由于这些方法有可能作为临床标准护理,因此对妇产科领域具有重要意义。已经为非整倍体和父系遗传显性特征建立了这种方法的概念验证。尽管最近取得了重大进展,但以隐性孟德尔方式分离的单基因疾病的非侵入性诊断仍然存在问题。微流控数字 PCR 和 DNA 测序的最新发展导致该领域的一些新进展。这些主要(尽管并非完全)用于开发非整倍体诊断方法。然而,鉴于其普遍性,这些方法很可能用于开发针对单基因疾病的非侵入性诊断方法。
考虑到这一点,我们在使用游离 DNA 进行产前诊断的情况下,对三种当代(数字)分析方法进行了统计建模,这些方法用于以隐性孟德尔方式分离的单基因疾病。我们为该背景下的诊断方法的未来发展提供了一个实验框架,在设计旨在该领域建立概念验证的分子检测时应予以考虑。